The ACTIV-2 trial will initially enrol 220 participants with mild or moderate COVID-19 who are at risk for disease progression.

COVID-19-Wochenhighlights aus der ganzen Welt: Israel führt das Impfrennen an, neue Virusvarianten ...

Findings suggest this antibiotic should be used with caution among all adults age 35 years or older.

More than half of the patients reported ongoing poor health, despite normal chest X-rays.

Filter face masks are particularly associated with the appearance of de novo headache in certain health workers.

A decision could be made at the next scheduled meeting of the EMA’s committee on human medicines on 29 January.

The Moderna vaccine is the second COVID-19 vaccine to receive approval from the European Medicines Agency.

All volunteers mounted an anti spike immune response following the second dose of the vaccine.

Document provides updated knowledge on the role of children in the transmission of SARS-CoV-2

Early results show that the REGN-COV2 antibody cocktail reduced viral load

Fokale Therapie weist frühe Wiederherstellung der Harn- und Sexualfunktionen auf.

Phase 3 trial of ADT added to radiotherapy or dose-escalated radiotherapy.

New variant of coronavirus should be closely monitored

European Medicines Agency has recommended granting a conditional marketing authorisation for the vaccine Comirnaty